I think it’s very good news. I’m impressed by the support from an expert from Tufts. This type of a vaccine is far safer than others currently further in development so a secondary focus on children and pregnant women is a great unchartered avenue. Joe did a great job on a complex deal involving lawyers etc from overseas and hopefully all aspects of this just keep moving forward while other deals are finalized in Canada and China.
(5)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links